HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,203,000 | -58.3% | 18,463 | -59.5% | 0.01% | -53.3% |
| Q1 2022 | $2,883,000 | -22.6% | 45,607 | -35.0% | 0.02% | -21.1% |
| Q4 2021 | $3,724,000 | -29.5% | 70,207 | -6.2% | 0.02% | -34.5% |
| Q3 2021 | $5,284,000 | -34.6% | 74,853 | -38.3% | 0.03% | -37.0% |
| Q2 2021 | $8,081,000 | -76.9% | 121,257 | -61.6% | 0.05% | -79.1% |
| Q1 2021 | $35,050,000 | -10.1% | 315,739 | -3.8% | 0.22% | -10.6% |
| Q4 2020 | $38,982,000 | +3.9% | 328,266 | -23.6% | 0.25% | -13.7% |
| Q3 2020 | $37,502,000 | +4954.2% | 429,825 | +5676.4% | 0.28% | +3462.5% |
| Q1 2020 | $742,000 | +194.4% | 7,441 | +158.7% | 0.01% | +100.0% |
| Q1 2019 | $252,000 | -48.9% | 2,876 | -66.1% | 0.00% | -66.7% |
| Q4 2017 | $493,000 | – | 8,491 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |